Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia

NCT03705858 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Due to difficulty in finalizing the contract

Conditions

Interventions

Sponsor

Joseph Jurcic